Abba Medix Group Acquires Licensed Producer & Seller of Medical Marijuana - Video News Alert on InvestmentPitch.com

May 08, 2015 2:00 PM EDT | Source: InvestmentPitch Media

Vancouver, British Columbia--(Newsfile Corp. - May 8, 2015) - Abba Medix Group, formerly Saratoga Electronic Systems, (CSE: ABA) has significantly advanced its position in the medical marijuana industry through the purchase of a licensed producer and seller. Abba has acquired Redecan Pharm, a private company owned by Richard Redekop.

InvestmentPitch.com has produced a "video news alert" which provides a brief overview of the company. If this link is not enabled, please visit www.InvestmentPitch.com and enter "Abba Medix" in the search box.


If you cannot view the video above, please visit:
http://www.investmentpitch.com/video/0_ikdnr7dx/Abba-Medix-Group-CSE-ABA-Acquires-Licensed-Producer-Seller-of-Medical-Marijuana

Redecan is focused on developing premium quality medical marijuana products and Mr. Redekop is a licensed producer and seller, able to cultivate marijuana under the Marihuana for Medical Purposes Regulations in Canada. Redekop obtained his medical marijuana production license in July 2014 and in March 2015 was awarded a full production and sales license.

Redekop, currently listed as one of the seventeen persons in Canada to obtain such a license, has applied to Health Canada to transfer and assign his MMPR license to Redecan Pharm. If such transfer is approved, the principal focus of Redecan will be the production of medical marijuana from its fully secured, 15,000 square-foot greenhouse production facility in Niagara, Ontario.

Terms of the agreement call for Abba to pay Redekop approximately $11 million, consisting of $8 million in cash and 6 million shares with a deemed value of $0.50 per share. Following the closing of the transaction, Redekop will hold 8.92% of Abba's outstanding shares.

Ray Rasouli, CEO of Abba stated: "We are very pleased to announce this vital transaction. Working with Richard and his team at Redecan these last few months we recognized their commitment to excellence in the medical marijuana field. We are delighted to have the opportunity to continue to work with Richard and his team to build a national, Canadian medical marijuana brand we can all be proud of."

In November 2013, Abba submitted its initial application under the MMPR licensing program for its 19,000 square foot growing facility in Pickering, Ontario, which has an output capacity of 115 kilograms of medical cannabis per month. This facility is complete and awaiting the Health Canada inspection.

The shares are current trading at $0.50.

For more information, please visit the company's website www.abbamedix.com or contact Ray Rasouli, CEO, at 905-492-9420 or email rayrasouli@abbamedix.com.

About InvestmentPitch

InvestmentPitch.com, a multimedia company that provides a combined solution for creating and hosting financial video content, and distributing it across multiple platforms to investors and financial professionals, specializes in producing short three minute videos based on significant news releases and research reports.

CONTACT:
InvestmentPitch.com
Barry Morgan, CFO
bmorgan@investmentpitch.com

info